z-logo
open-access-imgOpen Access
Circulating Fibroblast Growth Factor-21 Levels in Rheumatoid Arthritis: Associations With Disease Characteristics, Body Composition, and Physical Functioning
Author(s) -
Patrick Gould,
Babette S. Zemel,
Elena Taratuta,
Joshua F. Baker
Publication year - 2020
Publication title -
the journal of rheumatology/journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.577
H-Index - 178
eISSN - 1499-2752
pISSN - 0315-162X
DOI - 10.3899/jrheum.200673
Subject(s) - medicine , rheumatoid arthritis , resistin , lean body mass , fibroblast growth factor 23 , risk factor , adipokine , endocrinology , gastroenterology , obesity , insulin resistance , body weight , parathyroid hormone , calcium
This study evaluated associations between fibroblast growth factor (FGF)-21, an adipokine associated with metabolic stress, and adverse longitudinal changes in body composition and physical functioning in patients with rheumatoid arthritis (RA).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here